866-997-4948(US-Canada Toll Free)

United States Drugs for Schistosomiasis Market Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 100 Pages

In this report, the United States Drugs for Schistosomiasis market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Drugs for Schistosomiasis in these regions, from 2012 to 2022 (forecast).

United States Drugs for Schistosomiasis market competition by top manufacturers/players, with Drugs for Schistosomiasis sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Praziquantel
Oxamniquine
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Drugs for Schistosomiasis for each application, including
Haematobium
Mansoni
Japonicum
Mekongi
Intercalatum

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Drugs for Schistosomiasis Market Report 2017
1 Drugs for Schistosomiasis Overview
1.1 Product Overview and Scope of Drugs for Schistosomiasis
1.2 Classification of Drugs for Schistosomiasis by Product Category
1.2.1 United States Drugs for Schistosomiasis Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Drugs for Schistosomiasis Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Praziquantel
1.2.4 Oxamniquine
1.2.5 Other
1.3 United States Drugs for Schistosomiasis Market by Application/End Users
1.3.1 United States Drugs for Schistosomiasis Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Haematobium
1.3.3 Mansoni
1.3.4 Japonicum
1.3.5 Mekongi
1.3.6 Intercalatum
1.4 United States Drugs for Schistosomiasis Market by Region
1.4.1 United States Drugs for Schistosomiasis Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Drugs for Schistosomiasis Status and Prospect (2012-2022)
1.4.3 Southwest Drugs for Schistosomiasis Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Drugs for Schistosomiasis Status and Prospect (2012-2022)
1.4.5 New England Drugs for Schistosomiasis Status and Prospect (2012-2022)
1.4.6 The South Drugs for Schistosomiasis Status and Prospect (2012-2022)
1.4.7 The Midwest Drugs for Schistosomiasis Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Drugs for Schistosomiasis (2012-2022)
1.5.1 United States Drugs for Schistosomiasis Sales and Growth Rate (2012-2022)
1.5.2 United States Drugs for Schistosomiasis Revenue and Growth Rate (2012-2022)

2 United States Drugs for Schistosomiasis Market Competition by Players/Suppliers
2.1 United States Drugs for Schistosomiasis Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Drugs for Schistosomiasis Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Drugs for Schistosomiasis Average Price by Players/Suppliers (2012-2017)
2.4 United States Drugs for Schistosomiasis Market Competitive Situation and Trends
2.4.1 United States Drugs for Schistosomiasis Market Concentration Rate
2.4.2 United States Drugs for Schistosomiasis Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Drugs for Schistosomiasis Manufacturing Base Distribution, Sales Area, Product Type

3 United States Drugs for Schistosomiasis Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Drugs for Schistosomiasis Sales and Market Share by Region (2012-2017)
3.2 United States Drugs for Schistosomiasis Revenue and Market Share by Region (2012-2017)
3.3 United States Drugs for Schistosomiasis Price by Region (2012-2017)

4 United States Drugs for Schistosomiasis Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Drugs for Schistosomiasis Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Drugs for Schistosomiasis Revenue and Market Share by Type (2012-2017)
4.3 United States Drugs for Schistosomiasis Price by Type (2012-2017)
4.4 United States Drugs for Schistosomiasis Sales Growth Rate by Type (2012-2017)

5 United States Drugs for Schistosomiasis Sales (Volume) by Application (2012-2017)
5.1 United States Drugs for Schistosomiasis Sales and Market Share by Application (2012-2017)
5.2 United States Drugs for Schistosomiasis Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Drugs for Schistosomiasis Players/Suppliers Profiles and Sales Data
6.1 Shin Poong
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Drugs for Schistosomiasis Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.2 Drugs for Schistosomiasis Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Merck Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Bayer
6.3.2 Drugs for Schistosomiasis Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 EIPICO
6.4.2 Drugs for Schistosomiasis Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Chandra Bhagat Pharma
6.5.2 Drugs for Schistosomiasis Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Taj Pharmaceuticals
6.6.2 Drugs for Schistosomiasis Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
...

7 Drugs for Schistosomiasis Manufacturing Cost Analysis
7.1 Drugs for Schistosomiasis Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drugs for Schistosomiasis

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Drugs for Schistosomiasis Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drugs for Schistosomiasis Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Drugs for Schistosomiasis Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Drugs for Schistosomiasis Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Drugs for Schistosomiasis Sales Volume Forecast by Type (2017-2022)
11.3 United States Drugs for Schistosomiasis Sales Volume Forecast by Application (2017-2022)
11.4 United States Drugs for Schistosomiasis Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Drugs for Schistosomiasis
Figure United States Drugs for Schistosomiasis Market Size (K Pcs) by Type (2012-2022)
Figure United States Drugs for Schistosomiasis Sales Volume Market Share by Type (Product Category) in 2016
Figure Praziquantel Product Picture
Figure Oxamniquine Product Picture
Figure Other Product Picture
Figure United States Drugs for Schistosomiasis Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Drugs for Schistosomiasis by Application in 2016
Figure Haematobium Examples
Table Key Downstream Customer in Haematobium
Figure Mansoni Examples
Table Key Downstream Customer in Mansoni
Figure Japonicum Examples
Table Key Downstream Customer in Japonicum
Figure Mekongi Examples
Table Key Downstream Customer in Mekongi
Figure Intercalatum Examples
Table Key Downstream Customer in Intercalatum
Figure United States Drugs for Schistosomiasis Market Size (Million USD) by Region (2012-2022)
Figure The West Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Drugs for Schistosomiasis Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Drugs for Schistosomiasis Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Drugs for Schistosomiasis Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Drugs for Schistosomiasis Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Drugs for Schistosomiasis Sales Share by Players/Suppliers
Figure 2017 United States Drugs for Schistosomiasis Sales Share by Players/Suppliers
Figure United States Drugs for Schistosomiasis Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Drugs for Schistosomiasis Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Drugs for Schistosomiasis Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Drugs for Schistosomiasis Revenue Share by Players/Suppliers
Figure 2017 United States Drugs for Schistosomiasis Revenue Share by Players/Suppliers
Table United States Market Drugs for Schistosomiasis Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Drugs for Schistosomiasis Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Drugs for Schistosomiasis Market Share of Top 3 Players/Suppliers
Figure United States Drugs for Schistosomiasis Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Drugs for Schistosomiasis Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Drugs for Schistosomiasis Product Category
Table United States Drugs for Schistosomiasis Sales (K Pcs) by Region (2012-2017)
Table United States Drugs for Schistosomiasis Sales Share by Region (2012-2017)
Figure United States Drugs for Schistosomiasis Sales Share by Region (2012-2017)
Figure United States Drugs for Schistosomiasis Sales Market Share by Region in 2016
Table United States Drugs for Schistosomiasis Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Drugs for Schistosomiasis Revenue Share by Region (2012-2017)
Figure United States Drugs for Schistosomiasis Revenue Market Share by Region (2012-2017)
Figure United States Drugs for Schistosomiasis Revenue Market Share by Region in 2016
Table United States Drugs for Schistosomiasis Price (USD/Pcs) by Region (2012-2017)
Table United States Drugs for Schistosomiasis Sales (K Pcs) by Type (2012-2017)
Table United States Drugs for Schistosomiasis Sales Share by Type (2012-2017)
Figure United States Drugs for Schistosomiasis Sales Share by Type (2012-2017)
Figure United States Drugs for Schistosomiasis Sales Market Share by Type in 2016
Table United States Drugs for Schistosomiasis Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Drugs for Schistosomiasis Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drugs for Schistosomiasis by Type (2012-2017)
Figure Revenue Market Share of Drugs for Schistosomiasis by Type in 2016
Table United States Drugs for Schistosomiasis Price (USD/Pcs) by Types (2012-2017)
Figure United States Drugs for Schistosomiasis Sales Growth Rate by Type (2012-2017)
Table United States Drugs for Schistosomiasis Sales (K Pcs) by Application (2012-2017)
Table United States Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure United States Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure United States Drugs for Schistosomiasis Sales Market Share by Application in 2016
Table United States Drugs for Schistosomiasis Sales Growth Rate by Application (2012-2017)
Figure United States Drugs for Schistosomiasis Sales Growth Rate by Application (2012-2017)
Table Shin Poong Basic Information List
Table Shin Poong Drugs for Schistosomiasis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shin Poong Drugs for Schistosomiasis Sales Growth Rate (2012-2017)
Figure Shin Poong Drugs for Schistosomiasis Sales Market Share in United States (2012-2017)
Figure Shin Poong Drugs for Schistosomiasis Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Drugs for Schistosomiasis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Drugs for Schistosomiasis Sales Growth Rate (2012-2017)
Figure Merck Drugs for Schistosomiasis Sales Market Share in United States (2012-2017)
Figure Merck Drugs for Schistosomiasis Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Drugs for Schistosomiasis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer Drugs for Schistosomiasis Sales Growth Rate (2012-2017)
Figure Bayer Drugs for Schistosomiasis Sales Market Share in United States (2012-2017)
Figure Bayer Drugs for Schistosomiasis Revenue Market Share in United States (2012-2017)
Table EIPICO Basic Information List
Table EIPICO Drugs for Schistosomiasis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure EIPICO Drugs for Schistosomiasis Sales Growth Rate (2012-2017)
Figure EIPICO Drugs for Schistosomiasis Sales Market Share in United States (2012-2017)
Figure EIPICO Drugs for Schistosomiasis Revenue Market Share in United States (2012-2017)
Table Chandra Bhagat Pharma Basic Information List
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Chandra Bhagat Pharma Drugs for Schistosomiasis Sales Growth Rate (2012-2017)
Figure Chandra Bhagat Pharma Drugs for Schistosomiasis Sales Market Share in United States (2012-2017)
Figure Chandra Bhagat Pharma Drugs for Schistosomiasis Revenue Market Share in United States (2012-2017)
Table Taj Pharmaceuticals Basic Information List
Table Taj Pharmaceuticals Drugs for Schistosomiasis Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Taj Pharmaceuticals Drugs for Schistosomiasis Sales Growth Rate (2012-2017)
Figure Taj Pharmaceuticals Drugs for Schistosomiasis Sales Market Share in United States (2012-2017)
Figure Taj Pharmaceuticals Drugs for Schistosomiasis Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Schistosomiasis
Figure Manufacturing Process Analysis of Drugs for Schistosomiasis
Figure Drugs for Schistosomiasis Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Schistosomiasis Major Players/Suppliers in 2016
Table Major Buyers of Drugs for Schistosomiasis
Table Distributors/Traders List
Figure United States Drugs for Schistosomiasis Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Drugs for Schistosomiasis Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Drugs for Schistosomiasis Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Drugs for Schistosomiasis Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Drugs for Schistosomiasis Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Drugs for Schistosomiasis Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Drugs for Schistosomiasis Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Drugs for Schistosomiasis Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Drugs for Schistosomiasis Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Drugs for Schistosomiasis Sales Volume Share Forecast by Region (2017-2022)
Figure United States Drugs for Schistosomiasis Sales Volume Share Forecast by Region (2017-2022)
Figure United States Drugs for Schistosomiasis Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *